{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:40:37Z","timestamp":1792784437663,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1056,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.rmed.2010.04.006","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T04:47:16Z","timestamp":1276318036000},"page":"1482-1489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients"],"prefix":"10.1016","volume":"104","author":[{"given":"C.","family":"Verkindre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fukuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fl\u00e9male","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Overend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dolker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2010.04.006_bib1","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)"},{"key":"10.1016\/j.rmed.2010.04.006_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1183\/09031936.00082507","article-title":"Definition, epidemiology and natural history of COPD","volume":"30","author":"Viegi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.006_bib3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1378\/chest.120.4.1253","article-title":"Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD","volume":"120","author":"Taylor","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.04.006_bib4","first-page":"159","article-title":"Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients","volume":"47","author":"Cuvelier","year":"2002","journal-title":"Respir Care"},{"key":"10.1016\/j.rmed.2010.04.006_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.55.4.289","article-title":"A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group","volume":"55","author":"Van Noord","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.04.006_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.006_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0702573","article-title":"Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways","volume":"127","author":"Haddad","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"Suppl. 50","key":"10.1016\/j.rmed.2010.04.006_bib8","first-page":"3051","article-title":"NVA237, a once-daily inhaled anticholinergic, provides 24-hour bronchodilator efficacy in patients with moderate-to-severe COPD","volume":"28","author":"Singh","year":"2006","journal-title":"Eur Respir J"},{"issue":"Suppl. 51","key":"10.1016\/j.rmed.2010.04.006_bib9","first-page":"2135","article-title":"Efficacy and tolerability of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients","volume":"30","author":"Kuna","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.006_bib10","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)"},{"key":"10.1016\/j.rmed.2010.04.006_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows: report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: official statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.006_bib12","author":"The Japanese Respiratory Society"},{"key":"10.1016\/j.rmed.2010.04.006_bib13","series-title":"Experiments: design and analysis","isbn-type":"print","author":"John","year":"1977","ISBN":"https:\/\/id.crossref.org\/isbn\/0028472306"},{"key":"10.1016\/j.rmed.2010.04.006_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"issue":"Suppl. 52","key":"10.1016\/j.rmed.2010.04.006_bib15","first-page":"476s","article-title":"Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in patients with COPD","volume":"32","author":"Vogelmeier","year":"2008","journal-title":"Eur Respir J"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:03:36Z","timestamp":1760612616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611110001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0954611110001599"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2010.04.006","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2010.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}